Botulinum Toxin Market
The global botulinum toxin market was valued at US$ 4,527.0 Mn in 2017 and is projected to reach US$ 8,718.7 Mn by 2026, expanding at a CAGR of 7.6% from 2018 to 2026. Increase in the prevalence of spasticity and cervical dystonia and the number of cases of migraine is expected to drive the botulinum toxin market during the forecast period. Surge in the rate of adoption of non-surgical botulinum toxin procedures, due to their noninvasive or minimally invasive nature, is boosting botulinum toxin market. Rise in the number of worldwide geriatric population and incidences of esthetic issues, such as crow’s foot and lateral canthal lines, is a key factor that is anticipated to propel the botulinum toxin market during the forecast period. However, lack of awareness regarding the advancements in non-surgical esthetic and therapeutic procedures is a major factors hampering revenue generation in the global botulinum toxin market.
The global botulinum toxin market has been segmented into product type, application, and region. In terms of product type, the market has been classified into botulinum toxin type A and botulinum toxin type B. The botulinum toxin type A segment held a prominent share of the global botulinum toxin market in 2017. Increase in prevalence of cervical dystonia, spasticity, glabellar lines, and crow’s foot and rise in the use of botulinum toxin type A are key factors driving the market. The botulinum toxin type B segment is expected to expand at a considerable CAGR during the forecast period. Advantages of botulinum toxin type B, such as faster onset of action and faster recovery time, and introduction of new and improved type B products in the market for new indications are major factors propelling the segment. Based on application, the global botulinum toxin market has been segregated into esthetic and therapeutics. The therapeutics segment dominated the global botulinum toxin market in 2017, owing to global rise in the cases of migraine and increase in the demand for non-surgical therapeutic procedure, which is noninvasive or minimally invasive in nature. The esthetic segment is anticipated to expand at a higher CAGR during the forecast period, owing to the increase in prevalence of lateral canthal lines and face wrinkles.
Based on region, the global botulinum toxin market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global botulinum toxin market in 2017, owing to the rise in awareness level regarding non-surgical esthetic and therapeutic procedures. The botulinum toxin market in North America is expected to maintain its dominant position in the global market during the forecast period. The botulinum toxin market in Europe is expected to expand during the forecast period, due to increase in geriatric population. The market in Asia Pacific is projected to expand at a comparatively higher CAGR during the forecast period, owing to the rise in adoption of non-surgical botulinum toxin procedures by the geriatric population and favorable government regulations.
Prominent players operating in the global botulinum toxin market include Allergan, Inc., Ipsen Group, Merz Pharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Galderma, Metabiologics, Inc. (US), Lanzhou Institute of Biological Products Co. Ltd. and Revance Therapeutics, Inc. Allergan, Inc., Ipsen Group, and Merz Pharma GmbH & Co. KGaA are the prominent global market players in the botulinum toxin market. Allergan, Inc. has strong regional presence, either direct or through subsidiaries, distributors, and partnerships. Extensive research & development, international presence, robust marketing, and product reliability, provide the company, an upper hand over its competitors.
Next-Generation Sequencing Technologies Bolster Botulinum Toxin Market
There has been some fascinating research in utilizing the biologic and pharmacological properties of botulinum toxin (BT) in medical sciences. Amusingly, it is the first biological toxin that has found its way to disease biology, opening up massive vistas of possibilities for healthcare companies. The use of next-generation sequencing technologies has helped propelled the strides in the botulinum toxin (BT) market. Among the various subtypes of BT, the use of subtype A for botulinum neurotoxin therapy has gained substantial attention among players. Researchers have been able to establish its remarkable safety and its potential for use in both injectable and oral form. This is a key driver for new avenues in the BT market. Botulinum neurotoxins (BoNT) is considered to be promising in numerous cosmetic and therapeutic interventions. A great deal of the progress has been fuelled by growing understanding of the pharmacology of BoNT. Some of the avenues where market players see potential revenue streams from the use of BT injections are in facial rejuvenation, in treating primary axillary hyperhidrosis, and hemimasticatory spasm. One of the promising therapeutic areas where BT is showing vast potential is being used as a therapeutic alternative for spasticity management which also includes poststroke spasticity.
The Covid-19 pandemic has been cause of substantial morbidity and mortality in worldwide populations. Recently emergent variants have caused havoc in some regions of the world. Policy makers in collaboration with industry players are keen on consolidating the logistics and supply chain of vaccine development to distribution to the last mile. Vaccine developers have been benefitting from favorable regulatory outlook. A recent case in point is approval of an array of vaccines. A great deal of the efforts in developing promising vaccine candidates for SARS-CoV-2 has been cemented by valuable learnings scientists and vaccine manufacturers have gained from SARS-CoV and MERS-CoV. The success that some nations have achieved in vaccinating people across different age groups has boosted consumer sentiment and is expected to bolster macroeconomic fundamentals.
The global botulinum toxin market has been segmented as follows:
|
Product Type |
|
|
Application |
|
|
Region |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Botulinum Toxin Market
4. Market Overview
4.1. Introduction
4.1.1. by Product Type Definition
4.1.2. Market Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increasing demand for minimally invasive and non-invasive aesthetic and therapeutic procedures
4.3.1.2. Increase in prevalence of spasticity and cervical dystonia
4.3.1.3. Increasing number of products approval and new product launch in different region
4.3.1.4. Rising awareness regarding botulinum toxin procedures in the geriatric population worldwide
4.3.2. Restraints
4.3.2.1. Short time results and repetitive nature of aesthetic and therapeutic procedures
4.3.2.2. High cost of procedures and unavailability of reimbursement policies
4.3.3. Opportunities
4.3.3.1. Use of botulinum toxin products for the treatment of migraine and over sweating
4.3.3.2. Numerous products in phase III and above clinical trials for various disease conditions
4.4. Global Botulinum Toxin Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Price Comparison Analysis (2017)
5.2. Pipeline Analysis
5.3. Launch and Patent Expiry - Snapshot
5.4. Key Trends
5.4.1. Increasing use of botulinum toxin aesthetic treatments by men
5.4.2. New and improved approaches regarding formulation types and delivery of botulinum toxin products
6. Global Botulinum Toxin Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
6.3.1. Botulinum Toxin Type A
6.3.2. Botulinum Toxin Type B
6.4. Market Attractiveness by Product Type
7. Global Botulinum Toxin Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Botulinum Toxin Market Value Forecast, by Application, 2016–2026
7.3.1. Aesthetic
7.3.2. Therapeutics
7.4. Global Botulinum Toxin Market Attractiveness, by Application
8. Global Botulinum Toxin Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Botulinum Toxin Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Botulinum Toxin Market Attractiveness, by Region
9. North America Botulinum Toxin Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
9.2.1. Botulinum Toxin Type A
9.2.2. Botulinum Toxin Type B
9.3. North America Botulinum Toxin Market Value Forecast, by Application, 2016–2026
9.3.1. Aesthetic
9.3.2. Therapeutics
9.4. North America Botulinum Toxin Market Value Forecast, by Country, 2016–2026
9.4.1. U.S.
9.4.2. Canada
9.5. North America Botulinum Toxin Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Application
9.5.3. By Country
10. Europe Botulinum Toxin Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
10.2.1. Botulinum Toxin Type A
10.2.2. Botulinum Toxin Type B
10.3. Europe Botulinum Toxin Market Value Forecast, by Application, 2016–2026
10.3.1. Aesthetic
10.3.2. Therapeutics
10.4. Europe Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2016–2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Botulinum Toxin Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Application
10.5.3. By Country/Region
11. Asia Pacific Botulinum Toxin Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
11.2.1. Botulinum Toxin Type A
11.2.2. Botulinum Toxin Type B
11.3. Asia Pacific Botulinum Toxin Market Value Forecast, by Application, 2016–2026
11.3.1. Aesthetic
11.3.2. Therapeutics
11.4. Asia Pacific Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2016–2026
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Rest of Asia Pacific
11.5. Asia Pacific Botulinum Toxin Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By Application
11.5.3. By Country/Region
12. Latin America Botulinum Toxin Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
12.2.1. Botulinum Toxin Type A
12.2.2. Botulinum Toxin Type B
12.3. Latin America Botulinum Toxin Market Value Forecast, by Application, 2016–2026
12.3.1. Aesthetic
12.3.2. Therapeutics
12.4. Latin America Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2016–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Botulinum Toxin Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Botulinum Toxin Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
13.2.1. Botulinum Toxin Type A
13.2.2. Botulinum Toxin Type B
13.3. Middle East & Africa Botulinum Toxin Market Value Forecast, by Application, 2016–2026
13.3.1. Aesthetic
13.3.2. Therapeutics
13.4. Middle East & Africa Botulinum Toxin Market Value Forecast, by Country/Region, 2016–2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Botulinum Toxin Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by Tier and Size of companies)
14.2. Market Share Analysis by Company (2017)
14.3. Company Profiles
14.3.1. Allergan, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Ipsen Group
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Medytox, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Merz Pharma GmbH & Co. KGaA
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. US Worldmed, LLC
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.6. Nestlé Skin Health (Galderma)
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Metabiologics, Inc. (US)
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.8. Hugel Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Lanzhou Institute of Biological Products Co. Ltd.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Revance Therapeutics, Inc.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
List of Tables
Table 01: Global Botulinum Toxin Market: Pipeline Analysis
Table 02: Global Botulinum Toxin Market: Price Comparison Analysis
Table 03: Global Botulinum Toxin Market: Launch Snapshot
Table 04: Global Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 05: Global Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 06: Global Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 07: North America Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 08: North America Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 09: North America Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 10: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 11: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 12: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 13: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 14: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 15: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 16: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 17: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 18: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 19: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 20: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 21: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 22: Pipeline Products - Allergan plc
Table 23: Pipeline Products - Ipsen Pharma
Table 24: Pipeline Products - Medytox Inc.
Table 25: Pipeline Products - US Worldmed, LLC
Table 26: Pipeline Products - Revance Therapeutics, Inc.
List of Figures
Figure 01: Global Botulinum Toxin Market Value (US$ Mn) and Distribution, by Region, 2018 and 2026
Figure 02: Market Snapshot
Figure 03: Global Botulinum Toxin Market Value Share, Product Type, 2018 and 2026
Figure 04: Global Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type A, 2016–2026
Figure 05: Global Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type B, 2016–2026
Figure 06: Global Botulinum Toxin Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 07: Global Botulinum Toxin Market Value Share, by Application, 2018 and 2026
Figure 08: Global Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Aesthetic, 2016–2026
Figure 09: Global Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Therapeutics, 2016–2026
Figure 10: Global Botulinum Toxin Market Attractiveness, by Application, 2018–2026
Figure 11: Global Botulinum Toxin Market Value Share, by Region, 2018 and 2026
Figure 12: Global Botulinum Toxin Market Attractiveness, by Region, 2018–2026
Figure 13: North America Botulinum Toxin Market Value Share, Product Type, 2018 and 2026
Figure 14: North America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type A, 2016–2026
Figure 15: North America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type B, 2016–2026
Figure 16: North America Botulinum Toxin Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 17: North America Botulinum Toxin Market Value Share, by Application, 2018 and 2026
Figure 18: North America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Aesthetic, 2016–2026
Figure 19: North America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Therapeutics, 2016–2026
Figure 20: North America Botulinum Toxin Market Attractiveness, by Application, 2018–2026
Figure 21: North America Botulinum Toxin Market Value Share, by Region, 2018 and 2026
Figure 22: North America Botulinum Toxin Market Attractiveness, by Region, 2018–2026
Figure 23: Europe Botulinum Toxin Market Value Share, Product Type, 2018 and 2026
Figure 24: Europe Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type A, 2016–2026
Figure 25: Europe Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type B, 2016–2026
Figure 26: Europe Botulinum Toxin Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 27: Europe Botulinum Toxin Market Value Share, by Application, 2018 and 2026
Figure 28: Europe Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Aesthetic, 2016–2026
Figure 29: Europe Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Therapeutics, 2016–2026
Figure 30: Europe Botulinum Toxin Market Attractiveness, by Application, 2018–2026
Figure 31: Europe Botulinum Toxin Market Value Share, by Region, 2018 and 2026
Figure 32: Europe Botulinum Toxin Market Attractiveness, by Region, 2018–2026
Figure 33: Asia Pacific Botulinum Toxin Market Value Share, Product Type, 2018 and 2026
Figure 34: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type A, 2016–2026
Figure 35: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type B, 2016–2026
Figure 36: Asia Pacific Botulinum Toxin Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 37: Asia Pacific Botulinum Toxin Market Value Share, by Application, 2018 and 2026
Figure 38: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Aesthetic, 2016–2026
Figure 39: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Therapeutics, 2016–2026
Figure 40: Asia Pacific Botulinum Toxin Market Attractiveness, by Application, 2018–2026
Figure 41: Asia Pacific Botulinum Toxin Market Value Share, by Region, 2018 and 2026
Figure 42: Asia Pacific Botulinum Toxin Market Attractiveness, by Region, 2018–2026
Figure 43: Latin America Botulinum Toxin Market Value Share, Product Type, 2018 and 2026
Figure 44: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type A, 2016–2026
Figure 45: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type B, 2016–2026
Figure 46: Latin America Botulinum Toxin Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 47: Latin America Botulinum Toxin Market Value Share, by Application, 2018 and 2026
Figure 48: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Aesthetic, 2016–2026
Figure 49: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Therapeutics, 2016–2026
Figure 50: Latin America Botulinum Toxin Market Attractiveness, by Application, 2018–2026
Figure 51: Latin America Botulinum Toxin Market Value Share, by Region, 2018 and 2026
Figure 52: Latin America Botulinum Toxin Market Attractiveness, by Region, 2018–2026
Figure 53: Middle East & Africa Botulinum Toxin Market Value Share, Product Type, 2018 and 2026
Figure 54: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type A, 2016–2026
Figure 55: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type B, 2016–2026
Figure 56: Middle East & Africa Botulinum Toxin Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 57: Middle East & Africa Botulinum Toxin Market Value Share, by Application, 2018 and 2026
Figure 58: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Aesthetic, 2016–2026
Figure 59: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Therapeutics, 2016–2026
Figure 60: Middle East & Africa Botulinum Toxin Market Attractiveness, by Application, 2018–2026
Figure 61: Middle East & Africa Botulinum Toxin Market Value Share, by Region, 2018 and 2026
Figure 62: Middle East & Africa Botulinum Toxin Market Attractiveness, by Region, 2018–2026
Figure 63: Total Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
Figure 64: Research & Development Expense (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 65: Breakdown of Net Sales (%), by Region, 2017
Figure 66: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 67: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 68: Dysport Sales (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 69: Breakdown of Net Sales (%), by Region, 2017
Figure 70: Breakdown of Net Sales (%), by Business Segment, 2017
Figure 71: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 72: R&D Expenses (US$ Mn), 2014–2017
Figure 73: Gross Profit (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 74: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 75: Revenue (US$ Mn), by Region, 2017
Figure 76: Revenue (US$ Mn), by Segment, 2017
Figure 77: Breakdown of Net Sales (%), by Region, 2017
Figure 78: Breakdown of Net Sales (%), by Business Segment, 2017
Figure 79: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 80: R&D Expenses (US$ Mn), 2014–2017
Figure 81: Gross Profit (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 82: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 83: R&D Expenses (US$ Mn), 2014–2017
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes